Gut Hormone Profiles Following Bariatric Surgery Favor an Anorectic State, Facilitate Weight Loss, and Improve Metabolic Parameters
Carel W. le Roux(University College Dublin), Stephen R. Bloom(Imperial College London), Simon Aylwin(King's College Hospital NHS Foundation Trust), Cynthia-Michelle Borg, Sandra Shurey(Northwick Park Institute for Medical Research), Rachel L. Batterham(University College Hospital), Vyas Prasad(Clinical Nutrition Research Centre), Frances Coyle, Mohammad A. Ghatei(Hammersmith Hospital), Ameet G. Patel
Cited by 982
Related Papers
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
|New England Journal of Medicine|2015|2.6k
Inhibition of Food Intake in Obese Subjects by Peptide YY<sub>3–36</sub>
|New England Journal of Medicine|2003|1.6k
Definition and diagnostic criteria of clinical obesity
|The Lancet Diabetes & Endocrinology|2025|1.3k
Human distribution and release of a putative new gut hormone, peptide YY
|Gastroenterology|1985|1.1k
Joint international consensus statement for ending stigma of obesity
|Nature Medicine|2020|1.1k